MedTrace Logo

Maudsley Model of Anorexia Nervosa Treatment for Adolescents and Young Adults (MANTR-a)

NCT03535714 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-03-05

No results posted yet for this study

Summary

The aim of this study is to test effectiveness of a new treatment program for adolescents and young adults within the age of 14-21 suffering from AN (MANTR-a) compared to treatment as usual (TAU).

Conditions

  • Anorexia Nervosa
  • Anorexia

Interventions

BEHAVIORAL

MANTR-a treatment

MANTR-a treatment

Sponsors & Collaborators

  • Pharmig - Gesundheitsziele aus dem Rahmen-Pharmavertrag

    collaborator OTHER

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Andreas Karwautz, Univ.-Prof. · Medical University of Vienna

  • Gudrun Wagner, Ass.-Prof. · Medical University of Vienna

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-25
Primary Completion
2022-02-28
Completion
2022-08-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535714 on ClinicalTrials.gov